Expression analysis of the SG-SSPN complex in smooth muscle and endothelial cells of human umbilical cord vessels

Journal of Vascular Research

Volumn 42, Issue 1, 2005, Pages 1-7

  Ramirez Sanchez I ^a,b   Rosas Vargas, H ^a   Ceballos Reyes, G ^b   Salamanca, F ^a   Coral Vazquez R M ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Endothelium; Expression analysis; Sarcoglycan sarcospan complex; Sarcospan; Smooth muscle

Indexed keywords

CAVEOLIN; DYSTROPHIN; GLYCOPROTEIN IB; PROTEIN SUBUNIT; UTROPHIN;

ARTERY MUSCLE; ARTICLE; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MUSCLE CONTRACTILITY; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SMOOTH MUSCLE; UMBILICAL CORD;

CARRIER PROTEINS; CAVEOLIN 1; CAVEOLINS; ENDOTHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MEMBRANE PROTEINS; MUSCLE, SMOOTH, VASCULAR; NEOPLASM PROTEINS; RNA, MESSENGER; SARCOGLYCANS;

EID: 13244286597     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082528     Document Type: Article

References (39)

1. Angelini C: Advances and perspectives in muscular dystrophies. Basic Appl Myol 2002;12:17-25.
2. Dalkilic I, Kunkel LM: Muscular dystrophies: Genes to pathogenesis. Curr Opin Genet Dev 2003;13:231-238.
3. Hack AA, Groh M, McMally EM: Sarcoglycans in muscular dystrophy. Microsc Res Tech 2000;48:167-180.
4. Wheeler MT, Zarnegar S, McNally EM: ζ-Sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy. Hum Mol Genet 2002;11:2147-2154.
5. Crosbie RH, Lim LE, Moore SA, Hirano M, Hays AP, Maybaum SW, Collin H, Dovico SA, Stolle CA, Fardeau M, Tome FM, Campbell KP: Molecular and genetic characterization of sarcospan: Insights into sarcoglycan-sarcospan interactions. Hum Mol Genet 2000;9:2019-2027.
6. Roberds SL, Leturcq F, Allamand V, Piccolo F, Jeanpierre M, Anderson RD, Lim LE, Lee JC, Tome FM, Romero NB, Fardeau M, Beckman JS, Kaplan JC, Campbell KP: Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell 1994;78:625-633.
7. Bonnemann CG, Modi R, Noguchi S, Mizuno Y, Yoshida M, Gussoni E, McNally EM, Duggan DJ, Angelini C, Hoffman EP: Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet 1995;11:266-273.
8. Lim LE, Duclos F, Broux O, Bourg N, Sunada Y, Allamand V, Meyer J, Richard I, Moomaw C, Slaughter C, Tomé FMS, Fardeau M, Jackson CE, Beckman JS, Campbell KP: Beta-sarcoglycan: Characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet 1995;11:257-265.
9. Noguchi S, McNally EM, Ben Otmane K, Hagiwara Y, Mizuno Y, Yoshida M, Yamamoto H, Bonnemann CG, Gussoni E, Denton PH, Kyriakides T, Middleton L, Hentati F, Hamida MB, Nonaka I, Vance JM, Kunkel LM, Ozawa E: Mutations in the dystrophin-associated protein sarcoglycan in chromosome 13 muscular dystrophy. Science 1995;270:819-822.
10. Nigro V, de Sa Moreira E, Piluso G, Vainzof M, Belsito A, Politano L, Puca AA, Passos-Bueno MR, Zatz M: Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat Genet 1996;14:195-198.
11. Straub V, Ettinger AJ, Durbeej M, Venzke DP, Cutshall S, Sanes JR, Campbell KP: ε-Sarcoglycan replaces α-sarcoglycan in smooth muscle to form a unique dystrophin-glycoprotein complex. J Biol Chem 1999;274:27989- 27996.
12. Liu LA, Engvall E: Sarcoglycan isoforms in skeletal muscle. J Biol Chem 1999;274:38171-38176.
13. Sakamoto A, Ono K, Abe M, Jasmin G, Eki, T, Murakami Y, Masaki T, Toyo-oka T, Hanaoka F: Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: An animal model of disrupted dystrophin-associated glycoprotein complex. Proc Natl Acad Sci USA 1997;94:13873-13878.
14. Van der Kooi AJ, de Voogt WG, Barth PG, Busch HF, Jennekens FG, Jongen PJ, de Visser M: The heart in limb girdle muscular dystrophy. Heart 1998;79:73-77.
15. Melacini P, Fanin M, Duggan DJ, Freda MP, Berardinelli A, Danieli GA, Barchitta A, Hoffman EP, Dalla-Volta S, Angelini C: Heart involvement in muscular dystrophies due to sarcoglycan gene mutations. Muscle Nerve 1999;22:473-479.
16. Barresi R, Moore SA, Stolle A, Mendell R, Campbell KP: Expression of γ-sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complex. J Biol Chem 2000;275:38554-38560.
17. Tsubata S, Bowles KR, Vatta M, Zintz C, Titus J, Muhonen L, Bowles NE, Towbin JA: Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 2000;106:655-662.
18. Araishi K, Sasaoka T, Imamura M, Noguchi S, Hama H, Wakabayashi E, Yoshida M, Hori T, Ozawa E: Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice. Hum Mol Genet 1999;8:1589-1598.
19. Coral-Vázquez R, Cohn RD, Moore SA, Hill JA, Weiss RM, Davisson RL, Straub V, Barresi R, Bansal D, Hrstka RF, Williamson R, Campbell KP: Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscular dystrophy. Cell 1999;98:465-474.
20. Durbeej M, Cohn RD, Hrstka RF, Moore SA, Allamand V, Davidson BL, Williamson RA, Campbell KP: Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E. Mol Cell 2000;5:141-151.
21. Vainzof M, Passos-Bueno MR, Canovas M, Moreira ES, Pavanello RC, Marie SK, Anderson LV, Bonnemann CG, McNally EM, Nigro V, Kunkel LM, Zatz M: The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. Hum Mol Genet 1996;5:1963-1969.
22. Bonnemann CG, Passos-Bueno MR, McNally EM, Vainzof M, de Sa Moreira E, Marie SK, Pavanello RC, Noguchi S, Ozawa E, Zatz M, Kunkel LM: Genomic screening for beta-sarcoglycan gene mutations: Missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E). Hum Mol Genet 1996;5:1953-1961.
23. Duclos F, Straub V, Moore SA, Venzke DP, Hrstka RF, Crosbie RH, Durbeej M, Lebakken CS, Ettinger AJ, Van der Meulen J, Holt KH, Lim LE, Sanes JR, Davidson BL, Faulkner JA, Williamson R, Campbell KP: Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. J Cell Biol 1998;142:1461-1471.
24. Campbell KP: Three muscular dystrophies: Loss of cytoskeleton- extracellular matrix linkage. Cell 1995;80:675-679.
25. Rivier F, Robert A, Hugon G, Mornet D: Different utrophin and dystrophin properties related to their vascular smooth muscle distributions. FEBS Lett 1997;408:94-98.
26. North AJ, Galazkiewicz B, Byers TJ, Glenney JR Jr, Small JV: Complementary distributions of vinculin and dystrophin define two distinct sarcolemma domains in smooth muscle. J Cell Biol 1993;120:1159-1167.
27. Cohn RD, Durbeej M, Steve M, Coral-Vázquez R, Sally P, Campbell KP: Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex. J Clin Invest 2001;107:R1-R7.
28. Wheeler MT, Korcarz CE, Collins KA, Lapidos KA, Hack AA, Lyons KA, Zarnegar S, Earley JU, Lang RM, McNally EM: Secondary coronary artery vasospasm promotes cardiomyopathy progression. Am J Pathol 2004;164:1063-1071.
29. Ettinger AJ, Feng G, Sanes JR: Epsilon-sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D. J Biol Chem 1997;272:32534-32538.
30. Rando TA: The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve 2001;24:1575-1594.
31. Weir AP, Burton EA, Harrof G, Davies KE: A- and B-utrophin have different expression patterns and are differentially up-regulated in mdx mouse. J Biol Chem 2002;277:45285-45290.
32. Blake DJ, Hawkes R, Benson MA, Beesley PW: Different dystrophin-like complexes are expressed in neurons and glia. J Cell Biol 1999;147:645-658.
33. Loh NY, Newey SE, Davies KE, Blake DJ: Assembly of multiple dystrobrevin-containing complexes in the kidney. J Cell Sci 2000;13:2715-2724.
34. Zaccaria ML, Di Tommaso F, Brancaccio A, Paggi P, Petrucci TC: Dystroglycan distribution in adult mouse brain: A light and electron microscopy study. Neuroscience 2001;104:311-324.
35. Lumeng C, Phelps S, Crawford GE, Walden PD, Barald K, Chamberlain JS: Interactions between beta 2-syntrophin and a family of microtubule-associated serine/threonine kinases. Nat Neurosci 1999;2:611-617.
36. Hosokawa H, Ninomiya H, Kitamura Y, Fujiwara K, Masaki T: Vascular endothelial cells that express dystroglycan are involved in angiogenesis. J Cell Sci 2002;151:1487-1496.
37. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, Lisanti MP: Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 1996;271:15160-15165.
38. Sotgia F, Lee JK, Das K, Bedford M, Petrucci TC, Macioce P, Sargiacomo M, Bricarelli FD, Minetti C, Sudol M, Lisanti MP: Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan. Identification of a central WW-like domain within caveolin family members. J Biol Chem 2000;275:38048-38058.
39. Hagiwara Y, Nishina Y, Yorifuji H, Kikuchi T: Immunolocalization of caveolin-1 and caveolin-3 in monkey skeletal, cardiac and uterine smooth muscles. Cell Struct Funct 2002;27:375-382.